Afrin, N., Eisele, F., Stanojkovska, E., John, M., Fischer, H., Helal, M., Köchel, C., Kehl, N., Grundheber, L., Weis, P., Riedhammer, C., Kadel, S., Mersi, J., Steinbrunn, T., Waldschmidt, J., Kraus, S., Duell, J., Kortüm, K. M., Friedrich, M., Einsele, H., Riedel, A., Rasche, L. (2025). Increased teclistamab dosing interval improves T-cell diversity and reduces infection risk, while T-cell exhaustion remains minimal irrespective of schedule. Blood. https://doi.org/10.1182/blood-2025-802